Racine, A., R. Koscik, C. Nicholas, L. Clark, O. Okonkwo, J. Oh, A. Hillmer, D. Murali, T. Barnhart, T. Betthauser, C. Gallagher, H. Rowley, N. Dowling, S. Asthana, B. Bendlin, K. Blennow, H. Zetterberg, C. Carlsson, B. Christian, and S. Johnson. “Cerebrospinal Fluid Ratios With Aβ42 Predict Preclinical Brain β-Amyloid Accumulation.”. Alzheimer’s & Dementia (Amsterdam, Netherlands), Vol. 2, 2016, pp. 27-38.
Biomarkers are urgently needed for the critical yet understudied preclinical stage of Alzheimer’s disease (AD).
DOI: 10.1016/j.dadm.2015.11.006
PubMed: 26955655